Phase II study of PX-866 in recurrent glioblastoma.

导出 LinkOut

翻译打印收藏纠错

第一作者： Marshall W,Pitz

第一单位： CancerCare Manitoba, Winnipeg, Canada (M.W.P., S.B.); Queen's University, Department of Oncology, Kingston, Canada (E.A.E.); Dalhousie University,Halifax, Canada (M.V.M.); BritishColumbia Cancer Agency, Vancouver, Canada (B.T.); Tom Baker Cancer Centre, Calgary, Canada (J.C.E.); London Regional Cancer Program, London, Canada (D.R.M.); University of Alberta, Edmonton, Canada (D.D.E.); Allan Blair Cancer Center, Regina, Canada (A.S.K., M.S., H.C.); Department of Pathology and Molecular Medicine, Queen's University, Kingston, Canada (J.S.); Department of Pathology, University Health Network, University of Toronto, Toronto, Canada (M.S.T., S.K.-R.); NCIC Clinical Trials Group, Queen's University, Kingston, Canada (D.T., J.P.); Oncothyreon, Inc., Seattle, Washington (D.F.H.); Princess Margaret Cancer Centre, University of Toronto, Toronto, Canada (W.P.M.).

作者： Marshall W,Pitz ^[1] ; Elizabeth A,Eisenhauer ^[1] ; Mary V,MacNeil ^[1] ; Brian,Thiessen ^[1] ; Jacob C,Easaw ^[1] ; David R,Macdonald ^[1] ; David D,Eisenstat ^[1] ; Ankineedu S,Kakumanu ^[1] ; Muhammad,Salim ^[1] ; Haji,Chalchal ^[1] ; Jeremy,Squire ^[1] ; Ming Sound,Tsao ^[1] ; Suzanne,Kamel-Reid ^[1] ; Shantanu,Banerji ^[1] ; Dongsheng,Tu ^[1] ; Jean,Powers ^[1] ; Diana F,Hausman ^[1] ; Warren P,Mason ^[1]

作者单位： CancerCare Manitoba, Winnipeg, Canada (M.W.P., S.B.); Queen's University, Department of Oncology, Kingston, Canada (E.A.E.); Dalhousie University,Halifax, Canada (M.V.M.); BritishColumbia Cancer Agency, Vancouver, Canada (B.T.); Tom Baker Cancer Centre, Calgary, Canada (J.C.E.); London Regional Cancer Program, London, Canada (D.R.M.); University of Alberta, Edmonton, Canada (D.D.E.); Allan Blair Cancer Center, Regina, Canada (A.S.K., M.S., H.C.); Department of Pathology and Molecular Medicine, Queen's University, Kingston, Canada (J.S.); Department of Pathology, University Health Network, University of Toronto, Toronto, Canada (M.S.T., S.K.-R.); NCIC Clinical Trials Group, Queen's University, Kingston, Canada (D.T., J.P.); Oncothyreon, Inc., Seattle, Washington (D.F.H.); Princess Margaret Cancer Centre, University of Toronto, Toronto, Canada (W.P.M.). ^[1]

关键词 PI3K clinical trial glioblastoma